Bath & Body Works (NYSE:BBWI) Price Target Raised to $41.00

Bath & Body Works (NYSE:BBWI) had its target price boosted by equities research analysts at JPMorgan Chase & Co. from $39.00 to $41.00 in a note issued to investors on Friday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price indicates a potential upside of 10.02% from the company’s current price.

A number of other research firms also recently commented on BBWI. TD Cowen raised their target price on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. Argus reiterated a “hold” rating on shares of Bath & Body Works in a research note on Friday, January 10th. Piper Sandler boosted their price objective on shares of Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a research note on Monday, January 6th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Finally, Barclays lifted their price target on shares of Bath & Body Works from $28.00 to $34.00 and gave the stock an “underweight” rating in a report on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, six have given a hold rating and ten have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $43.19.

Bath & Body Works Stock Down 0.6 %

Shares of Bath & Body Works stock opened at $37.27 on Friday. Bath & Body Works has a 52 week low of $26.20 and a 52 week high of $52.99. The company has a market capitalization of $8.07 billion, a PE ratio of 9.09, a price-to-earnings-growth ratio of 1.01 and a beta of 1.82. The stock’s fifty day moving average is $36.76 and its two-hundred day moving average is $33.66.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.46 by $0.03. The business had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period last year, the company posted $0.48 earnings per share. As a group, research analysts anticipate that Bath & Body Works will post 3.26 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Fifth Third Wealth Advisors LLC grew its position in shares of Bath & Body Works by 4.9% during the 4th quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company’s stock valued at $271,000 after acquiring an additional 324 shares during the period. TD Private Client Wealth LLC boosted its position in Bath & Body Works by 24.2% during the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after purchasing an additional 331 shares in the last quarter. UMB Bank n.a. grew its holdings in Bath & Body Works by 58.8% in the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after purchasing an additional 335 shares during the period. Avior Wealth Management LLC increased its position in shares of Bath & Body Works by 30.3% in the fourth quarter. Avior Wealth Management LLC now owns 1,950 shares of the company’s stock valued at $76,000 after buying an additional 453 shares in the last quarter. Finally, GAMMA Investing LLC raised its stake in shares of Bath & Body Works by 34.4% during the 3rd quarter. GAMMA Investing LLC now owns 2,481 shares of the company’s stock worth $79,000 after buying an additional 635 shares during the period. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.